The Prescription Drug Affordability Board (PDAB) posted its agenda materials for the May 20 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted its draft agenda for the May 20 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy is seeking public feedback on proposed Pharmacy Prescription Locker (PPL) rules.
Please review each proposed rule and provide feedback in the comment boxes below each rule. The Board suggests reviewing questions #1 through #9 first and then going back to question #1 to provide your feedback.
The survey is available online. Please complete and submit your survey response by May 15.
The Board anticipates reviewing the public feedback received as well as the proposed rules during the June 11-12 Board Meeting.
Please note that these proposed rules are not currently in rulemaking, the Board is seeking public feedback at this time. Comments are not confidential and are subject to Oregon Public Records Law (ORS 192).
Also in Oregon, the Prescription Drug Affordability Board (PDAB) published the "Oregon PDAB Quarterly" newsletter, Issue 14.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted its draft agenda and meeting materials for the April 15 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy posted two current Board Member Opportunities:
Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted its draft agenda for the April 15 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy posted the April 8-10, 2026 Board Meeting Agenda and meeting materials. On page 4 of the agenda, please note the Rulemaking Policy Discussion Items scheduled on April 9. Additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted its draft agenda and meeting materials for the March 18 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy adopted the following Temporary Rule and Protocols:
February 25, 2026, Temporary Rule Noticed
Email all rulemaking related inquiries to pharmacy.rulemaking@bop.oregon.gov.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted its draft agenda and meeting materials for the February 18 meeting. Check the PDAB website for updates prior to the meeting. Register in advance.
Also in Oregon, the PDAB published its quarterly newsletter for January 2026. Past editions are available online.
Also in Oregon, the Oregon Health Authority (OHA) published a temporary rule adopting the new version of the High-Cost Drug Carve-Out (HCDCO) List effective February 1. In September 2025, OHA leadership and the Governor’s office agreed to implement a number of changes effective January 2026 that would reduce costs and administrative burden for coordinated care organizations (CCOs). Starting January 1, 2026, select high-cost drugs are carved out from CCO capitation. This is referred to as the High-Cost Drug Carve-Out (HCDCO). OHA reviews prior authorization (PA) requests for HCDCO products. Approved treatments will be covered by OHA directly on a fee-for-service (FFS) basis according to FFS reimbursement rules. CCOs are responsible for everything else, including care coordination, drug administration, inpatient stays, transportation, etc. There are 47 drugs on the initial HCDCO List. They all have a high cost ($500k or more per member per year) and treat a rare condition that has few, if any, other treatment alternatives. New drugs requested for review may be added to the HCDCO List up to four times a year following the rulemaking process if they meet these criteria.
Finally in Oregon, the Department of Human Services announced a new resource to help promote food resources across the state. Individuals may visit NeedFood.Oregon.gov to find food resources near them.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
